Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
February 02, 2018 16:30 ET
|
Dynavax Technologies Corporation
BERKELEY, Calif., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that on February 1, 2018 the Compensation Committee of Dynavax’s Board of Directors...
Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
January 12, 2018 16:01 ET
|
Dynavax Technologies Corporation
BERKELEY, Calif., Jan. 12, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that on January 10, 2018 the Compensation Committee of Dynavax’s Board of Directors...
Dynavax Announces HEPLISAV-B™ is Now Available in the United States for the Prevention of Hepatitis B in Adults
January 08, 2018 06:00 ET
|
Dynavax Technologies Corporation
BERKELEY, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] is now available...
Dynavax to Present at J.P. Morgan 36th Annual Healthcare Conference
January 04, 2018 06:00 ET
|
Dynavax Technologies Corporation
BERKELEY, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) announced today that Eddie Gray, Dynavax’s chief executive officer, will present at the J.P. Morgan...
Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
December 05, 2017 16:01 ET
|
Dynavax Technologies
BERKELEY, CA--(Marketwired - December 05, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that on November 28, 2017 the Compensation Committee of Dynavax's Board of Directors...
Dynavax to Present at the Evercore ISI Biopharma Catalyst/Deep Dive Conference
November 27, 2017 16:01 ET
|
Dynavax Technologies
BERKELEY, CA--(Marketwired - November 27, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that Eddie Gray, Dynavax's chief executive officer, will present at the Evercore ISI...
Dynavax Announces FDA Approval of HEPLISAV-B(TM) for Prevention of Hepatitis B in Adults
November 09, 2017 16:45 ET
|
Dynavax Technologies
BERKELEY, CA--(Marketwired - November 09, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved HEPLISAV-B [Hepatitis...
Dynavax Reports Third Quarter 2017 Financial Results
November 03, 2017 06:30 ET
|
Dynavax Technologies
BERKELEY, CA--(Marketwired - November 03, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the third quarter ended September 30, 2017. Cash, cash...
Dynavax Initiates Clinical Trial in Non-Small Cell Lung Cancer with a Novel Inhaled TLR9 Agonist in Combination with Anti-PD-1 Therapy
October 19, 2017 06:30 ET
|
Dynavax Technologies
BERKELEY, CA--(Marketwired - October 19, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced initiation of dosing in a phase 1B dose escalation clinical trial of its investigational...
Dynavax to Present at Upcoming Investor Conferences
September 05, 2017 06:00 ET
|
Dynavax Technologies
BERKELEY, CA--(Marketwired - September 05, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that the company will present at two upcoming investor conferences in...